首页|HRD1、P53、HER2水平与乳腺浸润性导管癌临床病理特征的关系

HRD1、P53、HER2水平与乳腺浸润性导管癌临床病理特征的关系

扫码查看
目的 研究HRD1、P53,HER2 与乳腺浸润性导管癌临床病理特征的关系.方法 选取确诊并实施相关治疗的82 例乳腺癌患者为此次试验的对象,收集全部患者的癌旁组织以及癌组织石蜡切片,应用免疫组织化学EliVi-sion两步法比较癌旁组织以及癌组织中HRD1、P53、HER2 水平,分析HRD1、P53、HER2 与乳腺浸润性导管癌临床病理特征的相关性.结果 癌组织中HRD1(χ2 =5.502,P =0.019)、P53(χ2 =6.552,P =0.011)、HER2(χ2 =5.512,P =0.023)的阳性表达率显著高于癌旁组织;脉管侵犯有无、不同肿瘤直径、TNM 不同分期以及淋巴结是否发生转移患者的 P53、HRD1、HER2 表达水平存在差异(P<0.05);相关性分析发现,患者的肿瘤直径、脉管侵犯、TNM分期以及淋巴结转移情况与患者的HRD1、P53、HER2 水平呈正相关.结论 HRD1、P53、HER2 与乳腺浸润性导管癌临床病理特征呈现显著的相关性,可作为日后治疗的重要靶点.
Relationship Between HRD1,P53,HER2 and Clinicopathological Features of Invasive Ductal Carcinoma of Breast
Objective To study the relationship between HRD1,P53,HER2 and clinicopathological features of invasive ductal carcinoma of the breast.Methods 82 patients with breast cancer diagnosed and treated were selected as the research ob-jects.The levels of HRD1,P53 and HER2 in adjacent and cancerous tissues were compared by immunohistochemical elivision two-step method,and the correlation between HRD1,P53 and HER2 and clinicopathological features of breast invasive ductal car-cinoma was analyzed.Results The positive expression rates of HRD1(χ2 =5.502,P =0.019),P53(χ2 =6.552,P =0.011)and HER2(χ2 = 5.512,P = 0.023)in cancer tissues were obvious higher than paracancerous tissues;there were significant differences in the expression levels of P53,HRD1 and HER2 in invalids with different tumor diameter,vascular invasion,TNM stage and lymph node metastasis(P<0.05);through correlation analysis,the expression levels of HRD1,P53 and HER2 in inva-lids with different tumor diameter,vascular invasion,TNM stage and lymph node metastasis were statistically significant(P<0.05)Tumor diameter,vascular invasion,TNM stage and lymph node metastasis were positively correlated with HRD1,P53 and HER2.Conclusion HRD1,P53,HER2 are significantly correlated with the clinicopathological features of breast invasive ductal carcinoma,which can be used as an important target for future treatment.

HRD1P53HER2Breast invasive ductal carcinomaCorrelation

陈岚

展开 >

471000 河南科技大学第一附属医院

HRD1 P53 HER2 乳腺浸润性导管癌 相关性

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(4)
  • 18